Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PNH - Paroxysmal Nocturnal Hemoglobinuria”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Early research (Phase 1)Active Not RecruitingNCT06848296
What this trial is testing

Phase Ib Clinical Study to Evaluate the Safety and Tolerability of VSA012 Injection in Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Bisirna Therapeutics Pte. Ltd. 50
Post-approval studies (Phase 4)UnknownNCT03866681
What this trial is testing

Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Peking Union Medical College Hospital 40
Not applicableEnrolling By InvitationNCT07657052
What this trial is testing

A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 26
Not applicableStudy completedNCT04128943
What this trial is testing

Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Aplastic AnemiaParoxysmal Nocturnal Hemoglobinuria
University Hospital, Basel, Switzerland 9
Early research (Phase 1)Ended earlyNCT01335165
What this trial is testing

Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alexion Pharmaceuticals, Inc. 10
Not applicableApproved For MarketingNCT00438789
What this trial is testing

The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol

Who this might be right for
Hemoglobinuria, Paroxysmal
Alexion Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT03588026
What this trial is testing

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
AKARI Therapeutics 9
Testing effectiveness (Phase 2)Study completedNCT03472885
What this trial is testing

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alexion Pharmaceuticals, Inc. 12
Early research (Phase 1)Study completedNCT06490991
What this trial is testing

Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT07212426
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.

Who this might be right for
PNH - Paroxysmal Nocturnal Hemoglobinuria
Longbio Pharma 30
Large-scale testing (Phase 3)Study completedNCT00098280
What this trial is testing

Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Hemoglobinuria, Paroxysmal
National Heart, Lung, and Blood Institute (NHLBI) 75
Testing effectiveness (Phase 2)Looking for participantsNCT01174108
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Who this might be right for
Severe Aplastic AnemiaMDS (Myelodysplastic Syndrome)
National Heart, Lung, and Blood Institute (NHLBI) 120
Large-scale testing (Phase 3)Study completedNCT00186823
What this trial is testing

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Leukemia, Acute Lymphocytic (ALL)Leukemia, Myeloid, Acute(AML)Leukemia, Myeloid, Chronic(CML)+4 more
St. Jude Children's Research Hospital 57
Not applicableActive Not RecruitingNCT05776472
What this trial is testing

A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Swedish Orphan Biovitrum 165
Testing effectiveness (Phase 2)Study completedNCT03078582
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 26
Not applicableLooking for participantsNCT06524726
What this trial is testing

The International PNH Interest Group PNH Registry

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
International PNH Interest Group 2,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT07177859
What this trial is testing

A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Nanjing Chia-tai Tianqing Pharmaceutical 78
Large-scale testing (Phase 3)Study completedNCT04085601
What this trial is testing

Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With PNH

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Apellis Pharmaceuticals, Inc. 53
Large-scale testing (Phase 3)Ended earlyNCT05131204
What this trial is testing

Efficacy and Safety of the Combination of Pozelimab and Cemdisiran Versus Continued Eculizumab or Ravulizumab Treatment in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Regeneron Pharmaceuticals 3
Next Page